Cognitive Impairment within Patients of Schizophrenia and Mood Disorder: A Comparative Study
Author(s) -
Swaroopa V. Lunge Patil,
Prakash B. Behere
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i60b34691
Subject(s) - mood , schizophrenia (object oriented programming) , psychiatry , cognition , psychology , bipolar disorder , executive dysfunction , mood disorders , clinical psychology , executive functions , cognitive impairment , brief psychiatric rating scale , medicine , psychosis , anxiety , neuropsychology
Background: Memory dysfunction, deficits in attention and executive functions as well impairment in cognition is found among patient suffering from Schizophrenia and Mood Disorder throughout the course of illness. All these significantly impact various domains of life in them. It also affects the patient’s insight into the illness and thus impairs therapeutic compliance.
Objectives:
To evaluate Cognitive functions in patients with Schizophrenia and Mood Disorder.
To compare both groups to see whether cognitive dysfunction varies between them.
Methodology:
Study Design: Cross-sectional study which is Hospital-based.
Study-Setting: The IPD and OPD of Psychiatry Department, AVBRH, Sawangi (M), Wardha.
Sample Size: 240 (120 patients with Schizophrenia and Mood Disorder each).
Patients clinically diagnosed having Schizophrenia and Mood disorder using ICD-10 criteria of age group 18-55 years, with at least 8 years of schooling will be included in the study after taking written informed consents. After collecting socio-demographic data and screening the patients with the Brief Psychiatric Rating Scale, the PGI Battery of Brain Dysfunction will be applied to the patients.
Results: This study will assess of impairment of Cognitive functions Schizophrenia as well as Mood Disorder patients would tell whether the cognitive impairment is the same or different in both groups.
Conclusion: Comparison of impairment in cognitive functions in Schizophrenia as well as Mood Disorder patients would be done. Co-relation of Cognitive impairment with Metabolic syndrome in both groups can be established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom